舒肝益肾方联合内分泌治疗激素依赖型乳腺癌患者的临床效果
CSTR:
作者:
作者单位:

作者简介:

通讯作者:

中图分类号:

基金项目:

2016年度河北省医学科学研究重点课题计划项目(20160590)


Clinical Study on Shugan Yishen Decoction Combined with Endocrine Therapy for Hormone-Dependent Breast Cancer
Author:
Affiliation:

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
  • 文章评论
    摘要:

    目的:探究舒肝益肾方联合内分泌对激素依赖型乳腺癌疗效,以期丰富治疗方法,提高疗效。方法:选取2014年1月至2018年12月秦皇岛市中医医院收治的激素依赖型乳腺癌患者94例作为研究对象,按照就诊顺序编号随机分为对照组和观察组,每组47例。对照组常规内分泌治疗,观察组在对照组基础上加用舒肝益肾方治疗,同时治疗4周。观察2组治疗前、治疗后肿瘤标志物、免疫功能、肝功能、凝血功能、生命质量、中医证候积分变化并比较。结果:治疗后2组癌抗原153(CA153)、糖链型抗原125(CA125)较治疗前显著下降,差异有统计学意义(P<0.05),治疗后观察组以上指标显著低于对照组,差异有统计学意义(P<0.05)。治疗后观察组CD3+、CD4+、CD4+/CD8+、自然杀伤细胞(NK)、IgA、IgG、IgM较治疗前显著升高,CD8+则显著下降,差异有统计学意义(P<0.05),对照组治疗前、治疗后比较,差异无统计学意义(P>0.05),治疗后观察组CD8+显著低于对照组,余均显著高于对照组,差异有统计学意义(P<0.05)。治疗后对照组总胆固醇(TC)、谷氨酰转肽酶(GCT)、纤维蛋白原(FIB)、部分凝血酶时间(APTT)较治疗前显著上升,差异有统计学意义(P<0.05),观察组治疗后和治疗前比较,差异无统计学意义(P>0.05),治疗后观察组以上指标显著低于对照组,差异有统计学意义(P<0.05)。治疗后2组躯体功能、角色功能、情绪功能、认知功能、社会功能、整体生命质量较治疗前显著升高,差异有统计学意义(P<0.05),治疗后观察组以上指标显著高于对照组,差异有统计学意义(P<0.05)。治疗后2组情志抑郁、不寐、心烦易怒、腰膝酸软、肢体受限较治疗前显著下降,差异有统计学意义(P<0.05),治疗后观察组以上指标显著低于对照组,差异有统计学意义(P<0.05)。结论:舒肝益肾方联合内分泌能提高激素依赖型乳腺癌免疫功能,抑制肿瘤进展,从而改善临床症状,提高生命质量。

    Abstract:

    To explore the therapeutic effects of Shugan Yishen Decoction combined with endocrine on hormone-dependent breast cancer, in order to enrich the treatment methods and improve the curative effect.Methods:A total of 94 patients with hormone-dependent breast cancer hospitalized in Qinhuangdao Chinese Medicine Hospital from January 2014 to December 2018 were randomly divided into a control group(47 cases)and an observation group(47 cases).The control group received routine endocrine therapy, while the observation group received Shugan Yishen Decoction on the basis of the control group for 4 weeks.The changes of tumor markers, immune function, liver function, blood coagulation function, quality of life and TCM syndrome scores before and after treatment were observed and compared between the 2 groups.Results:1)After treatment, CA125 and CA153 in the 2 groups were significantly decreased than those before treatment(P<0.05), and the above indexes in the observation group were significantly lower than those in the control group(P<0.05).2)After treatment, CD3+, CD4+, CD4+/CD8+, NK, IgA, IgG and IgM in the observation group increased significantly, while CD8+ decreased significantly(P<0.05).There was no significant difference between the control group before and after treatment(P>0.05).After treatment, CD8+ in the observation group was significantly lower than that in the control group, and the rest was significantly higher than that in the control group(P<0.05).3)After treatment, total cholesterol(TC), glutamyl transpeptidase(GCT), fibrinogen(FIB), and partial thrombin time(APTT)in the control group were significantly increased than those before treatment(P<0.05).There was no significant difference between the observation group after treatment and before treatment(P>0.05), and the above indexes in the observation group after treatment were significantly lower than those in the control group(P<0.05).4)After treatment, the physical function, role function, emotional function, cognitive function, social function and overall quality of life in the 2 groups were significantly increased than those before treatment(P<0.05), and the above indexes in the observation group were significantly higher than those in the control group(P<0.05).5)After treatment, depression, insomnia, irritability, weakness of waist and knee, limb limitation in both groups decreased significantly compared with before treatment(P<0.05).After treatment, the above indicators in the observation group were significantly lower than those in the control group(P<0.05).Conclusion:Shugan Yishen Decoction combined with endocrine can improve the immune function of hormone-dependent breast cancer, inhibit the progress of tumors, thereby improving clinical symptoms and quality of life.

    参考文献
    相似文献
    引证文献
引用本文

王晓玲,郑艺,李江涛.舒肝益肾方联合内分泌治疗激素依赖型乳腺癌患者的临床效果[J].世界中医药,2020,(03).

复制
相关视频

分享
文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:2019-03-20
  • 最后修改日期:
  • 录用日期:
  • 在线发布日期: 2020-03-16
  • 出版日期:
文章二维码